| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| First Wave BioPharma, Inc. | President & COO, Director | Common Stock, par value $0.0001 per share | 15,400 | 13 Mar 2024 | Indirect | ||
| First Wave BioPharma, Inc. | President & COO, Director | Series G Non-Voting Convertible Preferred Stock | 4,920 | 13 Mar 2024 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ENTO | First Wave BioPharma, Inc. | 13 Mar 2024 | 2 | $0 | 4 | President & COO, Director | 15 Mar 2024, 18:05 |
| ENTO | First Wave BioPharma, Inc. | 13 Mar 2024 | 0 | $0 | 3 | President & COO, Director | 15 Mar 2024, 18:00 |